C12Y 503/01016
1--5- imidazole-4-carboxamid
Official title: 1-(5-Phosphoribosyl)-5-((5-phosphoribosylamino)methylideneamino) imidazole-4-carboxamid (5.3.1.16)
C12Y503/01016 (1--5- imidazole-4-carboxamid) appears on 1 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 3
- Assignees
- 2
- Inventors
- 12
- Latest grant
- 29 Aug 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Engineered Biosynthetic Pathways for Production of Histamine by Fermentation18 Apr 2024US 2024/0124907 A1Zymergen Inc.
- Enhanced production of histidine, purine pathway metabolites, and plasmid dna2 Mar 2023US 2023/0065419 A1Ginkgo Bioworks, Inc.
- Engineered biosynthetic pathways for production of histamine by fermentation17 Jun 2021US 2021/0180096 A1Zymergen Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.